In this context, a previous study by our group [16], focused on HER2 over-expressing breast cancer cells, showed that PC-PLC physically associated with both HER2 and EGFR receptors and its inhibition resulted in a decrease in the overall cellular contents of EGFR, HER2 and HER3 receptors. This evidence concerns the gene HSPG2 and breast carcinoma.